2020
DOI: 10.1007/s00044-020-02530-7
|View full text |Cite
|
Sign up to set email alerts
|

Biologically active quinazoline-based hydroxamic acids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 83 publications
0
12
0
Order By: Relevance
“…Currently, it is also indicated that multifunctional hybrid compounds containing quinazoline/quinazolinone and other biologically active pharmacophores can potentially significantly increase the effectiveness of pharmacotherapy [ 141 ]. Osipov et al point out that hybrid compounds containing the quinazoline cycle may constitute the basis for the synthesis of effective drugs with great therapeutic potential in the complex treatment of oncological, neurological or infectious diseases [ 142 ]. There are many reports that show the therapeutic potential of various quinazoline/quinazolinone-based hybrid analogues against a wide range of diseases.…”
Section: Are Anticancer Quinazoline Derivatives Good Candidates To Be...mentioning
confidence: 99%
“…Currently, it is also indicated that multifunctional hybrid compounds containing quinazoline/quinazolinone and other biologically active pharmacophores can potentially significantly increase the effectiveness of pharmacotherapy [ 141 ]. Osipov et al point out that hybrid compounds containing the quinazoline cycle may constitute the basis for the synthesis of effective drugs with great therapeutic potential in the complex treatment of oncological, neurological or infectious diseases [ 142 ]. There are many reports that show the therapeutic potential of various quinazoline/quinazolinone-based hybrid analogues against a wide range of diseases.…”
Section: Are Anticancer Quinazoline Derivatives Good Candidates To Be...mentioning
confidence: 99%
“…For many reasons, investigation of the metal-binding properties of hydroxamic acidbased organic bioligands (containing at least one hydroxamic acid function, R C C(O)R N N(OH), where R C = alkyl or aryl; R N = H in primary derivatives, alkyl or aryl in secondary ones), whether naturally occurring or synthetic, has been a focus of interest for many decades. Most of the results are summarized in excellent reviews, some of which are referred here [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]. The previous results clearly demonstrate the significance of hydroxamatebased compounds in many fields, for example, they are known to play a crucial role in microbial iron uptake [3,5,6,11] and are capable of inhibiting a variety of enzymes, including ureases, peroxidases, and matrix metalloproteinases [8][9][10]14,16,[18][19][20][21][22][23][24][25].…”
Section: Introductionmentioning
confidence: 99%
“…Most of the results are summarized in excellent reviews, some of which are referred here [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]. The previous results clearly demonstrate the significance of hydroxamatebased compounds in many fields, for example, they are known to play a crucial role in microbial iron uptake [3,5,6,11] and are capable of inhibiting a variety of enzymes, including ureases, peroxidases, and matrix metalloproteinases [8][9][10]14,16,[18][19][20][21][22][23][24][25]. In correlation with these biological roles/effects, hydroxamate-based compounds are frequently used in the design of therapeutics targeting different diseases, like iron overload, cancers, microbial infections, inflammations, etc.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations